VISEN PHARMA-B(02561),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

02561 VISEN PHARMA-B

Noon Closed 04-02 12:30:00

53.300

+0.250

+0.47%

High54.950	Low52.150	Vol39.50K
Open53.100	D1 Closing53.050	Amplitude5.28%
Mkt Cap6.08B	Tradable Cap6.08B	Total Shares114.00M
T/O2.10M	T/O Rate0.03%	Tradable Shares114.00M
P/B14.54	ROE-47.83%	EPS0.00
52wk High69.150	52wk Low50.250	P/E--
Dividend0.00	Div.Yield0.00	ROA-14.69%

Disclaimer: HKEx Information Services Limited, its holding companies and/or any subsidiaries of such holding companies endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its absolute accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.

Invest in Global Markets with Tiger Brokers!

Open App

{"stockData":{"symbol":"02561","market":"HK","secType":"STK","nameCN":"VISEN PHARMA-B","latestPrice":53.3,"timestamp":1743568200021,"preClose":53.05,"halted":0,"volume":39500,"delay":0,"floatShares":113999999,"shares":113999999,"eps":0,"marketStatus":"Noon Closed","change":0.25,"latestTime":"04-02 12:30:00","open":53.1,"high":54.95,"low":52.15,"amount":2102300,"amplitude":0.05278,"askPrice":53.5,"askSize":500,"bidPrice":53.25,"bidSize":10000,"shortable":0,"etf":0,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1743570000000},"marketStatusCode":3,"adr":0,"listingDate":1742486400000,"exchange":"SEHK","adjPreClose":53.05,"openAndCloseTimeList":[[1743557400000,1743566400000],[1743570000000,1743580800000]],"volumeRatio":0.291963,"lotSize":100,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/02561/tweets","defaultTab":"tweets","newsList":[{"id":"2521141403","title":"Shares of Visen Pharmaceuticals  Set to Open at HK$68.80 Each in Hong Kong Debut VS Offer Price HK$68.80 Apiece","url":"https://stock-news.laohu8.com/highlight/detail?id=2521141403","media":"THOMSON REUTERS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2521141403?lang=en_us&edition=full_marsco","pubTime":"2025-03-21 09:21","pubTimestamp":1742520106,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250321:nL4N3Q403A:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["02561"],"gpt_icon":0},{"id":"2521624514","title":"BRIEF-Visen Pharmaceuticals Says Number Of Offer Shares Under Global Offering 11.4 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2521624514","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2521624514?lang=en_us&edition=full_marsco","pubTime":"2025-03-21 01:28","pubTimestamp":1742491685,"startTime":"0","endTime":"0","summary":"BRIEF-Visen Pharmaceuticals Says Number Of Offer Shares Under Global Offering 11.4 MillionMarch 20  - Visen Pharmaceuticals 2561.HK:NUMBER OF OFFER SHARES UNDER GLOBAL OFFERING 11.4 MILLIONFINAL OFFER PRICE UNDER GLOBAL OFFERING HK$68.80 PER SHARENUMBER OF HONG KONG OFFER SHARES UNDER GLOBAL OFFERING 4.6 MILLIONFurther company coverage: 2561.HK ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250320:nFWN3Q3146:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02561"],"gpt_icon":0},{"id":"2520445035","title":"Visen Pharmaceuticals -  Number of Offer Shares Under Global Offering 11.4 Mln","url":"https://stock-news.laohu8.com/highlight/detail?id=2520445035","media":"THOMSON REUTERS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520445035?lang=en_us&edition=full_marsco","pubTime":"2025-03-20 22:19","pubTimestamp":1742480384,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250320:nFWN3Q3146:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["02561"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.visenpharma.com","stockEarnings":[{"period":"1week","weight":-0.1158},{"period":"1month","weight":-0.2289},{"period":"ytd","weight":-0.2289}],"compareEarnings":[{"period":"1week","weight":-0.0059},{"period":"1month","weight":0.0116},{"period":"3month","weight":0.1569},{"period":"6month","weight":0.0494},{"period":"1year","weight":0.403},{"period":"ytd","weight":0.1569}],"compareStock":{"symbol":"HSI","name":"HSI"},"description":"Visen Pharmaceuticals is a holding company mainly engaged in developing and commercializing disruptive endocrine therapies. The Company's main products under development include lonapegsomatropin, navepegritide, and palopegteriparatide. The lonapegsomatropin is used to treat growth hormone deficiency in children aged 3 to 17 years old. The navepegritide is a disease repair therapy used to treat children with cartilage dysplasia aged 2 to 10 years old. The palopegteriparatide is a treatment method used to treat adult hypoparathyroidism. The Company is in the late stage of research and development, and its products are close to commercialization.","exchange":"SEHK","name":"VISEN PHARMA-B","nameEN":"VISEN PHARMA-B"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.32.1","shortVersion":"4.32.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"VISEN PHARMA-B(02561),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest VISEN PHARMA-B(02561) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"VISEN PHARMA-B,02561,VISEN PHARMA-B股票,VISEN PHARMA-B股票老虎,VISEN PHARMA-B股票老虎国际,VISEN PHARMA-B行情,VISEN PHARMA-B股票行情,VISEN PHARMA-B股价,VISEN PHARMA-B股市,VISEN PHARMA-B股票价格,VISEN PHARMA-B股票交易,VISEN PHARMA-B股票购买,VISEN PHARMA-B股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"VISEN PHARMA-B(02561),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest VISEN PHARMA-B(02561) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}